Published in Lab Business Week, September 18th, 2005
As of June 30, 2005, the company's balance of cash and cash equivalents totaled $60.2 million. During Q2, the company spent $13.3 million on investing activities, $8.4 million of which spending was incurred for the build-out the company's commercial manufacturing facility for AI-700.
The company's estimate of its total 2005 capital expenditures is unchanged from its Q1 report. Approximately $11.7 million and $3.2 million remaining to be paid for the manufacturing facility build-out and for equipment purchases, respectively,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.